These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7550849)

  • 1. [Early hematological consequences in infants born to HIV seropositive mothers treated with zidovudine during pregnancy].
    Tricoire J; Claeyssens S; Berrebi A; Izopet J; Rolland M
    Arch Pediatr; 1995 Aug; 2(8):800-1. PubMed ID: 7550849
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal short-course zidovudine reduces mortality in children born to human immunodeficiency virus-positive mothers in rural Kenya.
    Songok EM; Kakimoto K; Genga I; Okello C; Makokha E; Kageyama S; Kobayashi N; Fujiyama Y; Ichimura H
    J Infect Dis; 2001 May; 183(10):1540-2. PubMed ID: 11319695
    [No Abstract]   [Full Text] [Related]  

  • 4. Zidovudine in HIV-positive pregnant women and their babies.
    Samuel NM; Parameswari ; Kumari S
    Natl Med J India; 1996; 9(4):200-1. PubMed ID: 8772349
    [No Abstract]   [Full Text] [Related]  

  • 5. Providing AZT in pregnancy--if not now then when?
    Matchaba P
    S Afr Med J; 1999 Apr; 89(4):357. PubMed ID: 10341808
    [No Abstract]   [Full Text] [Related]  

  • 6. Zidovudine could stop HIV infection of babies.
    Dyer O
    BMJ; 1994 Jun; 308(6945):1661. PubMed ID: 8025456
    [No Abstract]   [Full Text] [Related]  

  • 7. Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France.
    Mayaux MJ; Teglas JP; Mandelbrot L; Berrebi A; Gallais H; Matheron S; Ciraru-Vigneron N; Parnet-Mathieu F; Bongain A; Rouzioux C; Delfraissy JF; Blanche S
    J Pediatr; 1997 Dec; 131(6):857-62. PubMed ID: 9427890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mother-to-child transmission of HIV].
    Garmark VC; Holmedal SH; Rønsen TK; Bruun JN; Lindemann R; Løkvik BH
    Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2029-32. PubMed ID: 12934123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiretroviral therapy in HIV/AIDS seropositive pregnant women in Cuba].
    González Núñez I; Díaz Jidy M; Pérez Avila J; Mengana Gutiérrez HL
    Rev Cubana Med Trop; 2004; 56(1):70-2. PubMed ID: 15849913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term observation on children. HIV-positive pregnant women: AZT therapy to be continued].
    Gürtler L
    Fortschr Med; 1999 Mar; 117(8):6. PubMed ID: 10220949
    [No Abstract]   [Full Text] [Related]  

  • 11. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
    Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
    JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pneumonia caused by measles in a pregnant woman with HIV antibodies. Response to treatment with immunoglobulins].
    Carmena J; Tornero C; Salcedo M; Perpiñán J; Pons E
    Enferm Infecc Microbiol Clin; 1996; 14(7):456-7. PubMed ID: 8991450
    [No Abstract]   [Full Text] [Related]  

  • 13. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.
    Fiscus SA; Adimora AA; Schoenbach VJ; Lim W; McKinney R; Rupar D; Kenny J; Woods C; Wilfert C
    JAMA; 1996 May; 275(19):1483-8. PubMed ID: 8622222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment failure of preventive zidovudine in maternal fetal transmission of HIV].
    Wirtgen P; Pons JC; Boubon MC; Taburet AM; Delfraissy JF; Horovitz J
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(3):289-92. PubMed ID: 8102148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV positive mothers and their children].
    Salo E; Savonius H; Leinikki P; Paavonen J; Suni J; Lähdevirta J
    Duodecim; 1998; 114(5):417-22. PubMed ID: 11466932
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The New York City Perinatal HIV Transmission Collaborative Study Group.
    Matheson PB; Abrams EJ; Thomas PA; Hernán MA; Thea DM; Lambert G; Krasinski K; Bamji M; Rogers MF; Heagarty M
    J Infect Dis; 1995 Aug; 172(2):353-8. PubMed ID: 7622877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case study: ethics consultation.
    Spike J; Greenlaw J
    J Law Med Ethics; 1994; 22(4):347-50. PubMed ID: 7767411
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing perinatal HIV infection. How far have we come?
    Simonds RJ; Rogers M
    JAMA; 1996 May; 275(19):1514-5. PubMed ID: 8622228
    [No Abstract]   [Full Text] [Related]  

  • 19. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
    Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants.
    Le Chenadec J; Mayaux MJ; Guihenneuc-Jouyaux C; Blanche S;
    AIDS; 2003 Sep; 17(14):2053-61. PubMed ID: 14502008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.